Viewing Study NCT04836884



Ignite Creation Date: 2024-05-06 @ 4:00 PM
Last Modification Date: 2024-10-26 @ 2:01 PM
Study NCT ID: NCT04836884
Status: COMPLETED
Last Update Posted: 2022-04-21
First Post: 2021-03-25

Brief Title: Vascular Anomaly Pathology and Genomics Biopsy Study
Sponsor: Mayo Clinic
Organization: Mayo Clinic

Study Overview

Official Title: Validation of Core Biopsy of Vascular Anomalies for Clinical Pathology and Genomics
Status: COMPLETED
Status Verified Date: 2022-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this research is to gather information on the safety and effectiveness of core biopsy of vascular anomalies for clinical pathology and clinical genomics studies
Detailed Description: Vascular anomalies or vascular malformations often are treated with minimally invasive sclerotherapy embolization or ablation based on clinical and imaging features without acquisition of tissue Over the last two decades there have been significant advancements in the understanding of the genetic basis for various vascular anomaliesmalformations which may guide use of therapies for individualized treatment

As such given the emergence of novel medications for treatment of vascular anomaliesmalformations based on genetic information acquisition of tissue for pathology and genomic characterization will be increasingly important as treatment of vascular anomaliesvascular malformations moves toward individualized medicine approach

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None